Nutrien Ltd. · Basic Materials
The price already needs more growth than analysts forecast, at both a 9% and an 8% discount rate.
Priced for 7% growth against flat consensus. At a 8.0% margin the price needs +7.1%/yr against +0.2% consensus, a -10.1pt cushion against a 0.0pt cut (rule: drowns, -8.7pt at 8.5%).
Would recover if: potash price falls. We re-check this against analyst estimates every evening.
10 years, at a 8% margin analysts expect
+1.1%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
6 published targets, set before the drop
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 296% of reported profit arrived as operating cash, so the analysts' margin stands.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 5, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price at the price sits at the 67th percentile of the $63–$80 published model range, broadly agreeing with the four endorsed models and explicitly rejecting the two bear cases that see 18–21% downside.
The price assumes an 8.3% revenue CAGR over the next decade supported by structural growth in emerging markets and sustained nitrogen margins; whether unit volumes in those segments actually accelerate can be measured, but the pricing power required to hold margins cannot be tested with the available data.
What the price refuses to pay for, and the full reconstruction, on the NTR quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names